The flow cytometry analysis of cells inducibly expressing MyD88L265P for 24 h revealed increased surface CD44 levels in U2932 lymphoma cells (Figure 5A) as well as other cell types, such as THP1 and U2OS (Figure S5A), which could be reverted with 5Z7O treatment (Figure 5B). The gene discussed is CD44; the disease is lymphoma.